Eastgate Biotech Corp. (ETBI) financial statements (2020 and earlier)

Company profile

Business Address 2681 EAST PARLEYS WAY - SUITE 204
SALT LAKE CITY, UT 84109
State of Incorp. NV
Fiscal Year End December 31
SIC 6799 - Investors, Not Elsewhere Classified (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments  192860100
Cash and cash equivalents  192860100
Receivables  8053  
Other undisclosed current assets  15  5
Total current assets:  1143400105
Noncurrent Assets
Property, plant and equipment  18414371 
Total noncurrent assets:  18414371 
TOTAL ASSETS:  29848372105
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 280361299  
Taxes payable 108    
Interest and dividends payable 433293183  
Other undisclosed accounts payable and accrued liabilities (262)68116  
Debt 108   
Due to related parties 2,096732389  
Deferred revenue and credits 93264  
Other undisclosed current liabilities 2,0991,6011,1892,399714
Total current liabilities: 4,5782,7291,8812,399714
Noncurrent Liabilities
Long-term debt and lease obligation, including: 4050   
Other undisclosed long-term debt and lease obligation 4050   
Total noncurrent liabilities: 4050   
Total liabilities: 4,6182,7791,8812,399714
Stockholders' equity
Stockholders' equity attributable to parent, including: (4,618)(2,481)(1,398)(2,327)(609)
Common stock 33 0 
Additional paid in capital 9,9709,1385,958135135
Accumulated other comprehensive income 4032150 
Accumulated deficit (14,631)(11,654)  (744)
Other undisclosed stockholders' equity attributable to parent   (7,371)(2,463)0
Total stockholders' equity: (4,618)(2,481)(1,398)(2,327)(609)
TOTAL LIABILITIES AND EQUITY:  29848372105

Income statement (P&L) ($ in thousands)

9/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
  132   
Cost of revenue
(Cost of Goods and Services Sold)
  (19)   
Gross profit:  113   
Operating expenses (2,634)(4,284)(4,819)(1,656)(606)
Other operating expense, net
(Other Expenses)
    (64)(17)
Operating loss: (2,634)(4,171)(4,819)(1,720)(623)
Nonoperating expense (344)(110)(89)  
Interest and debt expense (160)(110)(89)6417
Loss from continuing operations before equity method investments, income taxes: (3,137)(4,391)(4,997)(1,656)(606)
Other undisclosed income from continuing operations before income taxes 16011089  
Loss before gain (loss) on sale of properties: (2,977)(4,281)(4,908)(1,656)(606)
Other undisclosed net loss    (64) 
Net loss: (2,977)(4,281)(4,908)(1,720)(606)
Other undisclosed net loss attributable to parent     (17)
Net loss available to common stockholders, diluted: (2,977)(4,281)(4,908)(1,720)(623)

Comprehensive Income ($ in thousands)

9/30/2017
TTM
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss: (2,977)(4,281)(4,908)(1,720)(606)
Other comprehensive income    0 
Comprehensive loss: (2,977)(4,281)(4,908)(1,720)(606)
Other undisclosed comprehensive income, net of tax, attributable to parent 81715  
Comprehensive loss, net of tax, attributable to parent: (2,970)(4,265)(4,893)(1,720)(606)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: